date,title,source
Oct-31-18,Voyager Therapeutics to Host Third Quarter 2018 Financial Results and Corporate Highlights Conference Call,GlobeNewswire
Nov-07-18,Voyager Therapeutics: 3Q Earnings Snapshot,Associated Press
Nov-07-18,Voyager Therapeutics Announces Third Quarter 2018 Financial Results and Corporate Highlights,GlobeNewswire
Nov-07-18,Voyager Therapeutics Announces Positive Longer-Term Data for VY-AADC for Parkinsons Disease,GlobeNewswire
Nov-08-18,Edited Transcript of VYGR earnings conference call or presentation 7-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-08-18,"The Daily Biotech Pulse: Nantkwest Reports Positive Cancer Vaccine Trial Results, Sarepta Offering",Benzinga
Nov-19-18,Edited Transcript of VYGR earnings conference call or presentation 7-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-19-18,Voyager Therapeutics to Present at the Evercore ISI Healthcare Conference,GlobeNewswire
Nov-20-18,Edited Transcript of VYGR earnings conference call or presentation 7-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-23-18,"Report: Exploring Fundamental Drivers Behind Graphic Packaging Holding, QEP Resources, Inogen, CytRx, Voyager Therapeutics, and Daily Journal Corp. (S.C.)  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Nov-29-18,Voyager Therapeutics Enters into Strategic Manufacturing Collaborations with Brammer Bio and Fujifilm Diosynth Biotechnologies,GlobeNewswire
Dec-10-18,"Voyager Therapeutics Announces First Patient Dosed in RESTORE-1, a Phase 2 Trial of VY-AADC Gene Therapy for the Treatment of Parkinsons Disease",GlobeNewswire
Dec-17-18,Voyager Therapeutics Joins Michael J. Fox Foundation Initiatives and Education Campaigns to Accelerate the Development of New therapies and a Cure for Parkinsons Disease,GlobeNewswire
Jan-07-19,Voyager Therapeutics Provides Updates for VY-AADC Clinical Program for Parkinsons Disease,GlobeNewswire
Jan-15-19,"Voyager Therapeutics to Appoint Omar Khwaja, M.D., Ph.D., as Chief Medical Officer",GlobeNewswire
Jan-16-19,"Consolidated Research: 2019 Summary Expectations for Southern, Exelon, PriceSmart, Five Prime Therapeutics, Digi International, and Voyager Therapeutics  Fundamental Analysis, Key Performance Indications",GlobeNewswire
